DHEA (Dehydroisoandrosterone)是内源性甾体激素,可作为神经类固醇,与多种核与细胞表面受体相结合。
DHEA (Dehydroisoandrosterone) is an important endogenous steroid hormone; DHEA also has a variety of potential biological effects in its own right, binding to an array of nuclear and cell surface receptors and acting as a neurosteroid.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Kimonides VG, et al. Proc Natl Acad Sci U S A, 1998, 95(4), 1852-1857.
[2] Biochem. Biophys. Res. Commun. 243, 771. Majewska, M.D., et al. 1990. Brain Res. 526, 143.
分子式 C19H28O2 |
分子量 288.42 |
CAS号 53-43-0 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 50 mg/mL |
Water <1 mg/mL |
Ethanol 50 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT02357472 | Infertility | Drug: dehydroepiandrosterone | ShangHai Ji Ai Genetics & IVF Institute | Phase 4 | 2014-12-01 | 2015-11-16 |
NCT02866253 | Infertility | Drug: DHEA | ShangHai Ji Ai Genetics & IVF Institute | Phase 4 | 2014-12-01 | 2016-08-13 |
NCT02150330 | Dehydroepiandrosterone|DHEAS|Gene Expression of Cumulus Cells.|Ovarian Hyper-stimulation Protocol.|Artificial Reproduction Technology. | Drug: Dehydroepiandrosterone (DHEAS) | Taipei Veterans General Hospital, Taiwan|National YangMing University | Phase 3 | 2013-01-01 | 2014-05-26 |
NCT00575341 | Adrenal Insufficiency | Drug: Dehydroepiandrosterone|Drug: placebo | University Hospital Tuebingen | Phase 3 | 2003-10-01 | 2007-12-17 |
NCT00289926 | Quality of Life|Menopausal Syndrome|Libido Disorder | Drug: dehydroepiandrosterone|Drug: placebo | Monash University | Phase 3 | 2006-02-01 | 2016-03-15 |
NCT02099916 | Efficacy of DHEA|Pregnancy Rate|Diminished Ovarian Reserve|Changes in AMH | Drug: gonadotropins plus DHEA|Drug: Gonadotropins | University of Athens|Lito Maternity Hospital | Phase 2|Phase 3 | 2014-10-01 | 2014-09-09 |
NCT00900900 | Substance Withdrawal Syndrome | Dietary Supplement: dehydroepiandrosterone (DHEA)|Dietary Supplement: pregnenolone|Drug: Placebo | Jed E. Rose|Duke University | Phase 2 | 2009-07-01 | 2012-09-14 |
NCT01915186 | Female Infertility Due to Diminished Ovarian Reserve | Dietary Supplement: Dihydroepiandrosterone (DHEA) | The University of Hong Kong | 2010-10-01 | 2013-12-19 | |
NCT01256671 | Vaginal Atrophy | Drug: DHEA | EndoCeutics Inc. | Phase 3 | 2010-12-01 | 2016-02-19 |
NCT00429806 | Vaginal Atrophy | Drug: DHEA|Drug: Placebo | Centre Hospitalier Universitaire de Qu茅bec, CHU de Qu茅bec | Phase 1 | 2006-11-01 | 2016-03-19 |
NCT00581087 | Chronic Obstructive Pulmonary Disease|Hypertension, Pulmonary | Drug: DHEA treatment|Drug: Placebo | University Hospital, Bordeaux | Phase 3 | 2007-01-01 | 2015-01-13 |
NCT00650754 | Primary Ovarian Insufficiency|Unexplained Infertility | Dietary Supplement: Dehydroepiandrosterone|Other: Placebo | Center for Human Reproduction | Phase 2|Phase 3 | 2008-03-01 | 2015-09-28 |
NCT02561793 | Subfertility | Drug: DHEA|Drug: Placebo | Cairo University | Phase 3 | 2015-10-01 | 2016-07-03 |
NCT02432248 | Subfertility | Drug: Dehydroepiandrosterone|Other: placebo(medical starch) | The Affiliated Hospital of Inner Mongolia Medical University|First Affiliated Hospital, Sun Yat-Sen University|Renmin Hospital of Wuhan University | 2015-02-01 | 2015-04-28 | |
NCT00948857 | Premature Ovarian Failure | Dietary Supplement: Dehydroepiandrosterone|Dietary Supplement: Placebo | David H. Barad|Center for Human Reproduction | Phase 2|Phase 3 | 2009-06-01 | 2012-09-04 |
NCT01452373 | Vasomotor Symptoms|Hot Flushes | Drug: Placebo|Drug: DHEA and Acolbifene | EndoCeutics Inc. | Phase 3 | 2011-10-01 | 2013-12-10 |
NCT02683148 | Synovial Sarcoma|Sarcoma, Synovial | Drug: DHEA|Other: FACT-67 validated survey | Washington University School of Medicine | Phase 1|Phase 2 | 2016-09-13 | 2017-02-14 |
NCT01256684 | Vaginal Atrophy | Drug: Placebo|Drug: DHEA|Drug: DHEA | EndoCeutics Inc. | Phase 3 | 2010-12-01 | 2016-02-19 |
NCT01861847 | PTSD | Drug: 7-Keto Dehydroepiandrosterone|Drug: Placebo | Humanetics Corporation | Phase 2 | 2013-02-01 | 2015-10-07 |
NCT00419913 | Infertility|Decreased Ovarian Reserve | Dietary Supplement: Dehydroepiandrosterone | Center for Human Reproduction|Foundation for Reproductive Medicine | Phase 2|Phase 3 | 2007-01-01 | 2008-03-31 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们